Case report: successful treatment with cimetidine and zinc sulphate in chronic mucocutaneous candidiasis
Related Experiment Video
Updated: Oct 30, 2026

Rose Bengal-Mediated Photodynamic Therapy to Inhibit Candida albicans
Published on: March 24, 2022
B Polizzi1, L Origgi, G Zuccaro
1Institute of Internal Medicine, Infectious Disease and Immunopathology, Univerity of Milan, Italy.
Abstract:
The authors evaluated the clinical efficacy of a treatment with cimetidine and zinc sulphate in a patient with chronic mucocutaneous candidiasis. Cimetidine was given at a dose of 400 mg three times daily; zinc sulphate at a dose of 200 mg daily, then adjusted to maintain blood zinc levels at the upper normal range. This treatment lasted 16 months. An impressive and significant reduction of the infectious events and an increased CD4 (helper/inducer) cell counts were observed. The authors conclude that this combined immunopotentiating treatment is safe and inexpensive to treat immunodeficiency disorders.
Related Concept Videos
Cryptococcal Meningitis
Candidiasis

